MyAverix Finance
US · Healthcare
Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Biotechnology
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CTNM
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — FAQ
What is CTNM's P/E ratio?
The price-to-earnings (P/E) ratio for Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is 18.00 (data as of 2026-03-24).
Does Contineum Therapeutics, Inc. Class A Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Contineum Therapeutics, Inc. Class A Common Stock (CTNM). Check the MyAverix Finance app for the latest dividend data.
What sector is Contineum Therapeutics, Inc. Class A Common Stock in?
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CTNM listed on?
CTNM is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.